Paves the way for a stem cell bank of cord-blood derived iPSCs to advance regenerative medicine research Investigators at Johns Hopkins report they have developed human induced-pluripotent s... Read more
Rush University Medical Center is conducting the nation’s first clinical study of an innovative stem cell drug, Cartistem, to repair knee cartilage damaged by aging, trauma or degenerative d... Read more